Skip to main content
NameEmailPhD ProgramResearch InterestPublications
Peng, Aimin
WEBSITE
EMAIL
PUBLICATIONS

PHD PROGRAM
Cell Biology & Physiology, Oral & Craniofacial Biomedicine, Pathobiology & Translational Science

RESEARCH INTEREST
Biochemistry, Cancer Biology, Cancer Preclinical Models, Cancer Signaling & Biochemistry, Cell Biology, Cell Cycle, Drug Discovery

Our overarching goal is to delineate how cells respond to cancer therapeutics that induce DNA damage, and, accordingly, to develop new strategies that overcome treatment resistance in cancer, including head and neck cancer. To achieve this goal, we study new mechanisms of the cell cycle and DNA repair using comprehensive experimental systems; we investigate the involvement of these mechanisms in oral cancer progression and resistance; and we develop new therapeutics using cellular, biochemical, and pharmacological approaches.

Yates, Melinda

EMAIL
PUBLICATIONS

PHD PROGRAM
Pathobiology & Translational Science

RESEARCH INTEREST
Cancer Biology, Cancer Genomics, Cancer Preclinical Models, Cancer Signaling & Biochemistry, Pharmacology, Toxicology, Translational Medicine

Our translational research lab is focused on the earliest changes that occur in the uterus (endometrium) during cancer development related to obesity and hereditary DNA repair defects. We use preclinical tools (rodents, organoids, and cell lines) to probe mechanisms of endometrial cancer pathogenesis, in parallel with human tissue studies. Our overall goal is to understand how environmental factors, including obesity, hormones, and other exposures, influence endometrial cancer development and disparities so that we can use pharmacologic agents to prevent or reverse cancer development.